78 related articles for article (PubMed ID: 22679277)
1. A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines.
Dominska K; Piastowska-Ciesielska AW; Pluciennik E; Lachowicz-Ochedalska A; Ochedalski T
J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):74-81. PubMed ID: 22679277
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation.
Domińska K; Piastowska-Ciesielska AW; Lachowicz-Ochędalska A; Ochędalski T
Peptides; 2012 Oct; 37(2):200-6. PubMed ID: 22884921
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.
Sidorkiewicz M; Rebas E; Szymajda M; Ławnicka H; Pawlikowski M; Lachowicz A
Med Sci Monit; 2009 Apr; 15(4):BR106-10. PubMed ID: 19333191
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
Guimond MO; Battista MC; Nikjouitavabi F; Carmel M; Barres V; Doueik AA; Fazli L; Gleave M; Sabbagh R; Gallo-Payet N
Prostate; 2013 Jul; 73(10):1057-68. PubMed ID: 23389987
[TBL] [Abstract][Full Text] [Related]
6. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
[TBL] [Abstract][Full Text] [Related]
7. The influence of peptides from the angiotensin family on tyrosine kinase activity and cell viability in a human hormone-dependent prostate cancer line.
Domińska K; Piastowska AW; Rebas E; Lachowicz-Ochedalska A
Endokrynol Pol; 2009; 60(5):363-9. PubMed ID: 19885807
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
Zhao Y; Peng J; Zheng L; Yu W; Jin J
Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
[TBL] [Abstract][Full Text] [Related]
9. Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
Pérez-Díaz I; Guzmán C; Olivares-Reyes JA; Ramírez T; Gutierréz-Reyes G; Hiriart M; Robles-Díaz G
Pancreas; 2011 Jul; 40(5):701-7. PubMed ID: 21602736
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.
Redondo-Müller MA; Stevanovic-Walker M; Barker S; Puddefoot JR; Vinson GP
Endocr Relat Cancer; 2008 Mar; 15(1):277-88. PubMed ID: 18310294
[TBL] [Abstract][Full Text] [Related]
11. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
Aghaei M; Karami-Tehrani F; Panjehpour M; Salami S; Fallahian F
Prostate; 2012 Mar; 72(4):361-75. PubMed ID: 21656837
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
14. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM
Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan is a potent target for prevention and treatment in human prostate cancer.
Funao K; Matsuyama M; Kawahito Y; Sano H; Chargui J; Touraine JL; Nakatani T; Yoshimura R
Oncol Rep; 2008 Aug; 20(2):295-300. PubMed ID: 18636189
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II causes cellular proliferation in infantile haemangioma via angiotensin II receptor 2 activation.
Itinteang T; Marsh R; Davis PF; Tan ST
J Clin Pathol; 2015 May; 68(5):346-50. PubMed ID: 25713419
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA
Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314
[TBL] [Abstract][Full Text] [Related]
20. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator.
Dotan N; Wasser SP; Mahajna J
Integr Cancer Ther; 2011 Jun; 10(2):148-59. PubMed ID: 21147815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
